e-learning
resources
Barcelona 2010
Wednesday, 22.09.2010
Pathology and immunology of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lymphoid follicles in end-stage emphysema: Comparison of patients with or without α1-antitrypsin deficiency
F. Lunardi, E. Bazzan, S. Baraldo, K. Lokar-Oliani, A. Ballarin, M. Schiavon, G. Turato, E. Balestro, F. Rea, M. G. Cosio, F. Calabrese, M. Saetta (Padova, Italy; Montreal, Canada)
Source:
Annual Congress 2010 - Pathology and immunology of COPD
Session:
Pathology and immunology of COPD
Session type:
Oral Presentation
Number:
5344
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Lunardi, E. Bazzan, S. Baraldo, K. Lokar-Oliani, A. Ballarin, M. Schiavon, G. Turato, E. Balestro, F. Rea, M. G. Cosio, F. Calabrese, M. Saetta (Padova, Italy; Montreal, Canada). Lymphoid follicles in end-stage emphysema: Comparison of patients with or without α1-antitrypsin deficiency. Eur Respir J 2010; 36: Suppl. 54, 5344
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Mediators of lymphoid neogenesis in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Immune modulation of airways diseases
Year: 2010
Diffuse idiopathic pulmonary endocrine cell hyperplasia (DIPNECH) requiring bilateral sequential lung transplant
Source: Annual Congress 2013 –Modern approach to various clinical settings
Year: 2013
Ca 19-9 serum levels in patients with end-stage Idiopathic Pulmonary Fibrosis (IPF)
Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Year: 2018
Lymphoid follicles are a prominent feature in Idiopathic Pulmonary Fibrosis (IPF) lungs.
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019
Prevalence of adrenal insufficiency in patients started on Mepolizumab for severe eosinophilic asthma.
Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma
Year: 2019
Vitamin D serum level and pulmonary exacerbations in children with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children
Year: 2013
Biomarkers of early relapse of pulmonary exacerbation in cystic fibrosis adult patients
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013
Comparison between patients with idiopathic pulmonary fibrosis and patients with pulmonary involvement of the usual interstitial pneumonia pattern that preceded the onset of rheumatoid arthritis
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
Lung B cell-derived CXCL13 is critical for lymphoid follicle formation in chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Immunologic mechanisms in COPD and asthma
Year: 2012
Isolated mosaic pattern due to bronchiolitis in non-transplant patients: Etiology in 60 cases
Source: International Congress 2015 – Interstitial lung diseases I
Year: 2015
Index of histological activity in idiopathic pulmonary fibrosis (IPF) and chronic interstitial lung diseases (CHILD)
Source: Eur Respir J 2004; 24: Suppl. 48, 533s
Year: 2004
Phenotype of T cells in lung tissue from smokers with or without chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 53s
Year: 2005
Histopathological findings of biopsies from patients with extrinsic allergic alveolitis (hipersensitivity pneumonia) in subacute or chronic phase
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013
Fungal re-colonization in cystic fibrosis or bronchiectasis patients after lung transplantation: Incidence, time of onset and related-factors
Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Year: 2014
Localization of Granzyme A and B in lung specimens of patients with severe COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 207s
Year: 2003
Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2002; 20: Suppl. 38, 347s
Year: 2002
Chronic interstitial pneumonitis in end-stage sarcoidosis
Source: Eur Respir J 2010; 35: 695-697
Year: 2010
Subpopulation structure of lymphocytes in patients with chronic obstructive pulmonary disease (COPD) during exacerbation and after treatment
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008
Prognostic factors analysis of patients with acute exacerbation of idiopathic interstitial pneumonias treated by polymyxin B hemoperfusion
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013
Long-term treatment with nintedanib in patients with IPF: An update from INPULSIS®-ON
Source: International Congress 2016 – IPF treatment II
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept